Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.

Sorbello A, Jones SC, Carter W, Struble K, Boucher R, Truffa M, Birnkrant D, Gada N, Camilli S, Chan I, Dallas S, Scales T, Kosko R, Thompson E, Goodman J, Francis H, Dal Pan G.

Clin Infect Dis. 2012 Jul;55(1):1-7. doi: 10.1093/cid/cis351. Epub 2012 Apr 5.

2.

Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.

Hernandez JE, Adiga R, Armstrong R, Bazan J, Bonilla H, Bradley J, Dretler R, Ison MG, Mangino JE, Maroushek S, Shetty AK, Wald A, Ziebold C, Elder J, Hollister AS, Sheridan W; eIND Peramivir Investigators.

Clin Infect Dis. 2011 Mar 15;52(6):695-706. doi: 10.1093/cid/cir001.

3.

The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir.

Arya V, Carter WW, Robertson SM.

Clin Pharmacol Ther. 2010 Nov;88(5):587-9. doi: 10.1038/clpt.2010.187.

PMID:
20959843
4.

Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010.

Yu Y, Garg S, Yu PA, Kim HJ, Patel A, Merlin T, Redd S, Uyeki TM.

Clin Infect Dis. 2012 Jul;55(1):8-15. doi: 10.1093/cid/cis352. Epub 2012 Apr 5.

5.

Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.

Mancuso CE, Gabay MP, Steinke LM, Vanosdol SJ.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1240-9. doi: 10.1345/aph.1P031. Epub 2010 Jun 1. Review.

PMID:
20516360
6.

Safety and efficacy of peramivir for influenza treatment.

Hata A, Akashi-Ueda R, Takamatsu K, Matsumura T.

Drug Des Devel Ther. 2014 Oct 24;8:2017-38. doi: 10.2147/DDDT.S46654. eCollection 2014. Review.

7.

Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.

Louie JK, Yang S, Yen C, Acosta M, Schechter R, Uyeki TM.

PLoS One. 2012;7(6):e40261. doi: 10.1371/journal.pone.0040261. Epub 2012 Jun 29.

8.

Peramivir and its use in H1N1 influenza.

Castillo R, Holland LE, Boltz DA.

Drugs Today (Barc). 2010 Jun;46(6):399-408. doi: 10.1358/dot.2010.46.6.1459659. Review.

PMID:
20571608
9.

The emergency use authorization of peramivir IV: a view from the manufacturer.

Hollister AS, Sheridan WP.

Clin Pharmacol Ther. 2011 Feb;89(2):172-4. doi: 10.1038/clpt.2010.278.

PMID:
21252934
10.

Intravenous peramivir for treatment of influenza in hospitalized patients.

Ison MG, Fraiz J, Heller B, Jauregui L, Mills G, O'Riordan W, O'Neil B, Playford EG, Rolf JD, Sada-Diaz E, Elder J, Collis P, Hernandez JE, Sheridan WP.

Antivir Ther. 2014;19(4):349-61. doi: 10.3851/IMP2680. Epub 2013 Aug 28.

PMID:
23985625
11.

Peramivir: another tool for influenza treatment?

Jain S, Fry AM.

Clin Infect Dis. 2011 Mar 15;52(6):707-9. doi: 10.1093/cid/cir010. No abstract available.

12.

Response to several recent publications related to safety and efficacy of peramivir from the emergency use authorization experience.

Ison MG, Hollister AS, Sheridan WP.

Clin Infect Dis. 2013 Jan;56(1):164. doi: 10.1093/cid/cis800. Epub 2012 Sep 12. No abstract available.

13.

A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.

Ison MG, Hui DS, Clezy K, O'Neil BJ, Flynt A, Collis PJ, Simon TJ, Alexander WJ.

Antivir Ther. 2013;18(5):651-61. doi: 10.3851/IMP2442. Epub 2012 Oct 30.

PMID:
23111657
14.

Peramivir for the treatment of influenza.

Shetty AK, Peek LA.

Expert Rev Anti Infect Ther. 2012 Feb;10(2):123-43. doi: 10.1586/eri.11.174.

PMID:
22339187
15.

Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection.

Sugaya N, Kohno S, Ishibashi T, Wajima T, Takahashi T.

Antimicrob Agents Chemother. 2012 Jan;56(1):369-77. doi: 10.1128/AAC.00132-11. Epub 2011 Oct 24.

16.

Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014).

Chan-Tack KM, Kim C, Moruf A, Birnkrant DB.

Antivir Ther. 2015;20(5):561-4. doi: 10.3851/IMP2944. Epub 2015 Feb 10. Review.

PMID:
25667992
17.

Economic model for emergency use authorization of intravenous peramivir.

Lee BY, Tai JH, Bailey RR, McGlone SM, Wiringa AE, Zimmer SM, Smith KJ, Zimmerman RK.

Am J Manag Care. 2011 Jan;17(1):e1-9.

18.

Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients.

Kohno S, Kida H, Mizuguchi M, Hirotsu N, Ishida T, Kadota J, Shimada J; S-021812 Clinical Study Group.

Antimicrob Agents Chemother. 2011 Jun;55(6):2803-12. doi: 10.1128/AAC.01718-10. Epub 2011 Apr 4.

19.

Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.

Muñoz FM, Anderson EJ, Deville JG, Clinch B, Kamal MA.

Int J Clin Pharmacol Ther. 2015 Jul;53(7):531-40. doi: 10.5414/CP202307.

PMID:
26042486
20.

Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.

Yoo JW, Choi SH, Huh JW, Lim CM, Koh Y, Hong SB.

J Med Virol. 2015 Oct;87(10):1649-55. doi: 10.1002/jmv.24232. Epub 2015 May 6.

PMID:
25946636
Items per page

Supplemental Content

Write to the Help Desk